Natixis Advisors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,323
Closed -$1.98M 1736
2025
Q3
$1.98M Buy
23,323
+1,071
+5% +$85.8K ﹤0.01% 1108
2025
Q2
$1.74M Buy
22,252
+4,540
+26% +$335K ﹤0.01% 1128
2025
Q1
$1.28M Sell
17,712
-9,634
-35% -$808K ﹤0.01% 1207
2024
Q4
$2.43M Buy
27,346
+4,246
+18% +$378K ﹤0.01% 1034
2024
Q3
$1.96M Sell
23,100
-453
-2% -$40.2K ﹤0.01% 1093
2024
Q2
$2.18M Buy
23,553
+1,098
+5% +$111K ﹤0.01% 1020
2024
Q1
$2.53M Sell
22,455
-397
-2% -$39.6K 0.01% 965
2023
Q4
$2.13M Buy
22,852
+3,406
+18% +$300K 0.01% 986
2023
Q3
$1.78M Sell
19,446
-1,206
-6% -$130K 0.01% 1014
2023
Q2
$2.51M Buy
+20,652
New +$2.23M 0.01% 899

Other funds holding USPH

Natixis Advisors's USPH Position: Q4 2025 in Review

Natixis Advisors sold out of US Physical Therapy (USPH) in Q4 2025, closing a stake of 23,323 shares — an estimated $1.98M sold.

Natixis Advisors first reported a position in USPH in Q2 2023 and held it in 10 quarters. The position peaked at $2.53M in Q1 2024. 228 funds tracked by Wall St. Rank hold USPH as of Q4 2025.

  • Natixis Advisors reported no remaining US Physical Therapy position as of Q4 2025 after selling out during the quarter.
  • Natixis Advisors sold 23,323 US Physical Therapy shares in Q4 2025, an estimated $1.98M.
  • Natixis Advisors first reported a position in US Physical Therapy in Q2 2023 and held it in 10 quarters.
  • Natixis Advisors's US Physical Therapy position peaked at $2.53M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2025.

Based on Natixis Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.